Xiangnan Yu

4PUBLICATIONS
25CO-AUTHORS
Metabolic medicineCancer diagnosisMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 05, 2026
Indole-3-Acetic Acid Attenuates Metabolic-Associated Steatohepatitis via APC to Inhibit β-Catenin/Wnt Pathway.

Jia Chen, Xiang-Nan Yu, Fu-Lin Nian

|Feb 01, 2023
PRP19 Enhances Esophageal Squamous Cell Carcinoma Progression by Reprogramming SREBF1-Dependent Fatty Acid Metabolism.

Guang-Cong Zhang, Xiang-Nan Yu, Hong-Ying Guo

|Mar 28, 2022
microRNA-106b-5p Promotes Cell Growth and Sensitizes Chemosensitivity to Sorafenib by Targeting the BTG3/Bcl-xL/p27 Signaling Pathway in Hepatocellular Carcinoma.

Bilegsaikhan Enkhnaran, Guang-Cong Zhang, Ning-Ping Zhang

|Oct 18, 2021
Upregulation of Nei-Like DNA Glycosylase 3 Predicts Poor Prognosis in Hepatocellular Carcinoma.

Dongyu Wu, Guangcong Zhang, Jiamei Ma

Pageof 1

Frequent Collaborators

2 joint publications

Guang-Cong Zhang

2 joint publications

Ji-Min Zhu

2 joint publications

Tao-Tao Liu

2 joint publications

Ling Dong